Chiome Bioscience Inc. (TYO:4583)
133.00
-5.00 (-3.62%)
Sep 10, 2025, 3:30 PM JST
Chiome Bioscience Revenue
Chiome Bioscience had revenue of 113.10M JPY in the quarter ending June 30, 2025, a decrease of -15.65%. This brings the company's revenue in the last twelve months to 768.88M, up 30.92% year-over-year. In the year 2024, Chiome Bioscience had annual revenue of 780.81M with 14.41% growth.
Revenue (ttm)
768.88M
Revenue Growth
+30.92%
P/S Ratio
11.77
Revenue / Employee
14.51M
Employees
53
Market Cap
9.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 780.81M | 98.35M | 14.41% |
Dec 31, 2023 | 682.46M | 51.65M | 8.19% |
Dec 31, 2022 | 630.82M | -82.12M | -11.52% |
Dec 31, 2021 | 712.93M | 232.08M | 48.26% |
Dec 31, 2020 | 480.85M | 33.28M | 7.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |